Five Steps to Improve Cardiac Safety of Attention Deficit Hyperactivity Disorder Treatment.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2024, v. 29, n. 6, p. 670, doi. 10.5863/1551-6776-29.6.670
- By:
- Publication type:
- Article
Works by Stutzman, Danielle
Results: 8
1
2
Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2024, v. 29, n. 3, p. 215, doi. 10.5863/1551-6776-29.3.215
- By:
- Publication type:
- Article
3
Pitolisant in an Adolescent with Prader-Willi Syndrome.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 4, p. 405, doi. 10.5863/1551-6776-26.4.405
- By:
- Publication type:
- Article
4
Olanzapine-Induced Withdrawal Oculogyric Crisis in an Adolescent With a Neurodevelopmental Disorder.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
5
The Use of N-acetylcysteine Supplementation to Decrease Irritability in Four Youths With Autism Spectrum Disorders.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 2, p. 149, doi. 10.5863/1551-6776-25.2.149
- By:
- Publication type:
- Article
6
Acetylcysteine for treatment of autism spectrum disorder symptoms.
- Published in:
- American Journal of Health-System Pharmacy, 2015, v. 72, n. 22, p. 1956, doi. 10.2146/ajhp150072
- By:
- Publication type:
- Article
7
Role of Board‐Certified Psychiatric Pharmacists in child and adolescent psychiatry.
- Published in:
- JACCP: Journal of the American College of Clinical Pharmacy, 2024, v. 7, n. 2, p. 149, doi. 10.1002/jac5.1880
- By:
- Publication type:
- Article
8
The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study.
- Published in:
- Pediatric Reports, 2021, v. 13, n. 3, p. 421, doi. 10.3390/pediatric13030049
- By:
- Publication type:
- Article